| Disease burden of COPD in China: a systematic review |
26 |
| Role of inflammatory cells in airway remodeling in COPD |
24 |
| Long-term effects of oxygen-enriched high-flow nasal cannula treatment in COPD patients with chronic hypoxemic respiratory failure |
20 |
| Economic burden of COPD in a Swedish cohort: the ARCTIC study |
17 |
| Status of and strategies for improving adherence to COPD treatment |
16 |
| Early life insults as determinants of chronic obstructive pulmonary disease in adult life |
16 |
| Triple therapy (ICS/LABA/LAMA) in COPD: time for a reappraisal |
16 |
| Inhaled corticosteroids for chronic obstructive pulmonary disease: what is their role in therapy? |
15 |
| Geographical distribution of COPD prevalence in Europe, estimated by an inverse distance weighting interpolation technique |
15 |
| Gender-specific estimates of COPD prevalence: a systematic review and meta-analysis |
15 |
| High flow nasal cannula oxygen therapy versus non-invasive ventilation for chronic obstructive pulmonary disease with acute-moderate hypercapnic respiratory failure: an observational cohort study |
14 |
| Nasal high-flow versus noninvasive ventilation in patients with chronic hypercapnic COPD |
14 |
| Harmful impact of air pollution on severe acute exacerbation of chronic obstructive pulmonary disease: particulate matter is hazardous |
13 |
| Activity-related dyspnea in chronic obstructive pulmonary disease: physical and psychological consequences, unmet needs, and future directions |
13 |
| COPD: understanding patients' adherence to inhaled medications |
13 |
| Role of eosinophils in airway inflammation of chronic obstructive pulmonary disease |
12 |
| Personalized medicine for patients with COPD: where are we? |
12 |
| Effect of tele-health care on quality of life in patients with severe COPD: a randomized clinical trial |
12 |
| The effect of electronic cigarette and tobacco smoke exposure on COPD bronchial epithelial cell inflammatory responses |
12 |
| Increased serum IL-17 and decreased serum IL-10 and IL-35 levels correlate with the progression of COPD |
12 |
| Efficacy of supervised maintenance exercise following pulmonary rehabilitation on health care use: a systematic review and meta-analysis |
11 |
| Blood eosinophils: a biomarker of COPD exacerbation reduction with inhaled corticosteroids |
11 |
| Eosinophil counts in first COPD hospitalizations: a comparison of health service utilization |
11 |
| Mortality in COPD patients according to clinical phenotypes |
10 |
| Validity of ICD9-CM codes to diagnose chronic obstructive pulmonary disease from National Health Insurance claim data in Taiwan |
10 |
| Clinical utility of fractional exhaled nitric oxide and blood eosinophils counts in the diagnosis of asthma-COPD overlap |
10 |
| Medication adherence and persistence in chronic obstructive pulmonary disease patients receiving triple therapy in a USA commercially insured population |
10 |
| Improved lung function and patient-reported outcomes with co-suspension delivery technology glycopyrrolate/formoterol fumarate metered dose inhaler in COPD: a randomized Phase III study conducted in Asia, Europe, and the USA |
10 |
| Validation of clinical control in COPD as a new tool for optimizing treatment |
10 |
| Significances of spirometry and impulse oscillometry for detecting small airway disorders assessed with endobronchial optical coherence tomography in COPD |
10 |
| Long-term macrolide treatment for the prevention of acute exacerbations in COPD: a systematic review and meta-analysis |
10 |
| Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD |
10 |
| The YKL-40 protein is a potential biomarker for COPD: a meta-analysis and systematic review |
10 |
| Maintenance inhaler preference, attribute importance, and satisfaction in prescribing physicians and patients with asthma, COPD, or asthma-COPD overlap syndrome consulting for routine care |
9 |
| Defining the role of neutrophil-to-lymphocyte ratio in COPD: a systematic literature review |
9 |
| LABA/LAMA fixed-dose combinations in patients with COPD: a systematic review |
9 |
| The role of CAT in evaluating the response to treatment of patients with AECOPD |
9 |
| Long-term safety of bilateral targeted lung denervation in patients with COPD |
9 |
| The effects of single inhaler triple therapy vs single inhaler dual therapy or separate triple therapy for the management of chronic obstructive pulmonary disease: a systematic review and meta-analysis of randomized controlled trials |
9 |
| Effectiveness of meditative movement on COPD: a systematic review and meta-analysis |
9 |
| Effectiveness of water-based Liuzijue exercise on respiratory muscle strength and peripheral skeletal muscle function in patients with COPD |
9 |
| Autophagy, selective autophagy, and necroptosis in COPD |
9 |
| Chronic cough as a novel phenotype of chronic obstructive pulmonary disease |
9 |
| Impact of COPD on prognosis of lung cancer: from a perspective on disease heterogeneity |
8 |
| Intra- and inter-rater reproducibility of the 6-minute walk test and the 30-second sit-to-stand test in patients with severe and very severe COPD |
8 |
| Mixed Th2 and non-Th2 inflammatory pattern in the asthma-COPD overlap: a network approach |
8 |
| Factors associated with appropriate inhaler use in patients with COPD - lessons from the REAL survey |
8 |
| The impact of exposure to biomass smoke versus cigarette smoke on inflammatory markers and pulmonary function parameters in patients with chronic respiratory failure |
8 |
| Interventions to increase referral and uptake to pulmonary rehabilitation in people with COPD: a systematic review |
8 |
| Congenital lobar emphysema: diagnosis and treatment options |
8 |
